PGNX Shares Outstanding History



Below is a table of the PGNX shares outstanding history going back to 3/5/2010:

Date PGNX Shares Outstanding
3/5/201032.23M
5/5/201032.40M
8/4/201032.81M
11/3/201033.04M
3/4/201133.36M
5/4/201133.54M
8/3/201133.71M
11/2/201133.76M
3/5/201233.86M
5/1/201233.86M
8/3/201233.88M
11/5/201233.92M
3/8/201351.13M
5/7/201351.04M
8/9/201360.82M
11/6/201360.83M
3/7/201469.58M
5/2/201469.56M
8/4/201469.56M
11/3/201469.56M
3/10/201569.64M
5/1/201569.64M
8/3/201569.68M
11/3/201569.81M
3/7/201669.95M
5/2/201669.95M
7/28/201669.99M
11/3/201670.05M
3/6/201770.19M
5/1/201770.23M
8/4/201770.27M
10/30/201770.27M
3/5/201872.66M
5/4/201873.72M
7/26/201875.36M
11/5/201884.54M
3/11/201984.54M
4/25/201984.54M
5/6/201984.54M
8/5/201986.42M
1/12/201515.03M
11/4/201986.42M
3/9/202086.60M
5/4/202086.60M

Also see: PGNX Market Cap History
PGNX YTD Return
PGNX Historical Shares Outstanding:
+10.21% CAGR
PGNX Historical Shares Outstanding: +10.21% CAGR

Mouse over chart for data details
3/5/2010 ...5/4/2020
Progenics Pharmaceuticals is an oncology company focused on the development and commercialization of medicines and artificial intelligence to find, fight and follow cancer. Co.'s product candidates include: AZEDRA® (iobenguane I 131), which is a radiotherapeutic for the treatment of adult and pediatric patients 12 years and older with iobenguane scan positive or metastatic pheochromocytoma or paraganglioma who require systemic anticancer therapy; and 1095, which is a prostate-specific membrane antigen-targeted iodine-131 labeled small molecule that is designed to deliver a dose of beta radiation directly to prostate cancer cells with minimal impact on the surrounding healthy tissues. We show 44 historical shares outstanding datapoints in our coverage of PGNX's shares outstanding history.

Understanding the changing numbers of PGNX shares outstanding — and comprehending the concept of differing number of shares outstanding in general comparing companies like PGNX versus peers — is critical for investors. Many "beginner" or "novice" investors will look at one stock trading at a price of $10 per share and another trading at a price of $20 per share and think the latter company is worth twice as much. Of course, that is a completely meaningless comparison without also knowing how many shares outstanding there are for each of the two companies. Furthermore, via issuance of new shares over time, or the repurchase of existing shares, the number of shares outstanding can fluctuate over the course of history. With this page we aim to empower investors researching PGNX by allowing them to research PGNX shares outstanding history as well as any other stock in our coverage universe.
Quotes delayed 20 minutes

Email EnvelopeFree PGNX Email Alerts:
Get Dividend Alerts
Get SEC Filing Alerts
10 ETFs With Stocks That Insiders Are Buying
10 ETFs With Most Upside To Analyst Targets
The DividendRank Top 25
Warren Buffett Dividend Stocks
10 Cheap Dividend Stocks Under $10
10 Energy Stocks You Can Buy Cheaper Than Insiders Did
10 Top DividendRank'ed Energy Stocks
The 10 Highest Yielding Preferred Stocks
The 10 Highest Yielding Preferred Stocks
The 15 Most Active Call & Put Options of the S&P 500 Components
Video: Shares Outstanding Importance


If the video does not load after a few moments, Upgrade to the Latest Flash Player.
Progenics Pharmaceuticals (PGNX) is categorized under the Healthcare sector; to help you further research historical shares outstanding numbers, below are some other companies in the same sector:

PGNY Shares Outstanding History
PHAS Shares Outstanding History
PHAT Shares Outstanding History
PHIO Shares Outstanding History
PIII Shares Outstanding History
PIRS Shares Outstanding History
PKI Shares Outstanding History
PLRX Shares Outstanding History
PLSE Shares Outstanding History
PLUR Shares Outstanding History
More Healthcare companies »

 

PGNX Shares Outstanding History | www.SharesOutstandingHistory.com | Copyright © 2017 - 2024, All Rights Reserved

Nothing in SharesOutstandingHistory.com is intended to be investment advice, nor does it represent the opinion of, counsel from, or recommendations by BNK Invest Inc. or any of its affiliates, subsidiaries or partners. None of the information contained herein constitutes a recommendation that any particular security, portfolio, transaction, or investment strategy is suitable for any specific person. All viewers agree that under no circumstances will BNK Invest, Inc,. its subsidiaries, partners, officers, employees, affiliates, or agents be held liable for any loss or damage caused by your reliance on information obtained. By visiting, using or viewing this site, you agree to the following Full Disclaimer & Terms of Use and Privacy Policy. Video widget and market videos powered by Market News Video. Quote and option data delayed at least 15 minutes; stock quote data powered by Ticker Technologies, and Mergent.
X
Wait! Don't leave yet.
Want to receive our latest research absolutely free?


Click the button below for your complimentary copy of Your Early Retirement Portfolio: Dividends Up to 8.7%—Every Month—Forever.

You'll discover the details on 4 stocks and funds that pay you massive dividends as high as 8.7%.